Examining the clinical use of hemochromatosis genetic testing

Canadian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 1, 2015, Pages 41-45

  Lanktree, Matthew B ^a   Lanktree, Bruce B ^a   Paré, Guillaume ^a   Waye, John S ^a   Sadikovic, Bekim ^a   Crowther, Mark A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Genetic testing; Hemochromatosis; Iron; Phlebotomy

Indexed keywords

BIOCHEMICAL MARKER; FERRITIN; HEMOGLOBIN; IRON; LIVER ENZYME; TRANSFERRIN; HEMOCHROMATOSIS PROTEIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHLEBOTOMY; PRIORITY JOURNAL; AGED; BLOOD; ECONOMICS; GENETICS; METABOLISM; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; FERRITINS; GENETIC TESTING; GUIDELINE ADHERENCE; HEMOCHROMATOSIS; HEMOCHROMATOSIS PROTEIN; HEMOGLOBINS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHLEBOTOMY; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TRANSFERRIN;

EID: 84922455882     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2015/941406     Document Type: Article

References (24)

1. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004;350:2383-97.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-22.
4. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010;53:3-22.
5. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G. A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
6. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: A 17-year study. Mayo Clin Proc 2004;79:309-13.
7. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54:328-43.
8. Pietrangelo A, Caleffi A, Corradini E. Non-HFE hepatic iron overload. Semin Liver Dis 2011;31:302-18.
9. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65, 238 persons. Scand J Gastroenterol 2001;36:1108-15.
10. McLaren CE, McLachlan S, Garner CP, et al. Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations. PLoS One 2012;7:e38339.
11. Adams PC. H63D genotying for hemochromatosis: Helper or hindrance? Can J Gastroenterol Hepatol 2014;28:179-80.
12. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: A more effective approach. Blood 2008;111:3373-6.
13. Schranz M, Talasz H, Graziadei I, et al. Diagnosis of hepatic iron overload: A family study illustrating pitfalls in diagnosing hemochromatosis. Diagn Mol Pathol 2009;18:53-60.
14. Aguilar-Martinez P, Grandchamp B, Cunat S, et al. Iron overload in HFE C282Y heterozygotes at first genetic testing: A strategy for identifying rare HFE variants. Haematologica 2011;96:507-14.
15. Chandrasekharan S, Pitlick E, Heaney C, Cook-Deegan R. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis. Genet Med 2010;12 (4 Suppl):S155-70.
16. Van Wagner LB, Green RM. Elevated serum ferritin. JAMA 2014;312:743-4.
17. Barton JC, Lafreniere SA, Leiendecker-Foster C, et al. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. Am J Hematol 2009;84:710-4.
18. Del-Castillo-Rueda A, Moreno-Carralero MI, Cuadrado-Grande N, et al. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Gene 2012;508:15-20.
19. Yin D, Kulhalli V, Walker AP. Raised serum ferritin concentration in hereditary hyperferritinemia cataract syndrome is not a marker for iron overload. Hepatology 2014;59:1204-6.
20. Pelucchi S, Mariani R, Calza S, et al. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p. C282Y homozygous patients. Haematologica 2012;97:1818-25.
21. Van Der Harst P, Zhang W, Mateo Leach I, et al. Seventy-five genetic loci influencing the human red blood cell. Nature 2012;492:369-75.
22. McLaren CE, Garner CP, Constantine CC, et al. Genome-wide association study identifies genetic loci associated with iron deficiency. PLoS One 2011;6:e17390.
23. Johansen CT, Dubé JB, Loyzer MN, et al. LipidSeq: A next-generation clinical resequencing panel for monogenic dyslipidemias. J Lipid Res 2014;55:765-72.
24. Millat G, Chanavat V, Rousson R. Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies. Clin Chim Acta 2014;433:266-71.